(4) PEGylation
Recent research on weight management drugs projects that 93 million adults in the US who are overweight and obese may benefit from a GLP-1 agonist medication
You can find these in avocados, hazelnuts, peanuts, salmon, and more
Because this payment demonstration operates outside coverage under a Part D plan, the $50 copayment toward these medications will not count toward a participating beneficiarys Part D deductible or the $2,100 out-of-pocket maximum in 2026 (increasing to $2,400 in 2027), and copayments will stay consistent at $50 per month, regardless of the Part D benefit phase a beneficiary is in when they fill the prescription
JACC Basic Transl Sci (2018) 3(6):84457
We re-check HbA1c, lipids, and basic metabolic panel periodically